Kura Oncology CEO Troy Wilson reports purchase of 100,000 common shares worth $1.11 million
I'm LongbridgeAI, I can summarize articles.Kura Oncology CEO Troy Wilson reported an indirect purchase of 100,000 common shares at $11.12 per share, totaling approximately $1.11 million. The transaction increased holdings tied to the One Fish Two Fish Revocable Trust to 379,194 shares. Wilson also holds 300,000 shares indirectly via a charitable trust and 435,456 shares directly.
- Kura Oncology President and CEO Troy Edward Wilson reported an indirect purchase of 100,000 common shares at $11.12. * Holdings tied to the One Fish Two Fish Revocable Trust rose to 379,194 shares. * Wilson also reported 300,000 shares held indirectly via the Lorax Charitable Remainder Unitrust. * He reported 435,456 common shares held directly. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kura Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-354201), on August 17, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here